BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 34953404)

  • 21. Lessons learned from the delivery of virtual integrative oncology interventions in clinical practice and research during the COVID-19 pandemic.
    Knoerl R; Phillips CS; Berfield J; Woods H; Acosta M; Tanasijevic A; Ligibel J
    Support Care Cancer; 2021 Aug; 29(8):4191-4194. PubMed ID: 33772364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The COVID-19 pandemic as a catalyst for innovation: a regulatory framework to assess fit-for-purpose innovative approaches in clinical research.
    Leyens L; Simkins T; Horst NK
    Trials; 2022 Sep; 23(1):833. PubMed ID: 36180960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outpatient Palliative Care Practice for Cancer Patients During COVID-19 Pandemic: Benefits and Barriers of Using Telemedicine.
    Silva MD; Schack EE
    Am J Hosp Palliat Care; 2021 Jul; 38(7):842-844. PubMed ID: 33657873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimizing telemedicine to facilitate amyotrophic lateral sclerosis clinical trials.
    Govindarajan R; Berry JD; Paganoni S; Pulley MT; Simmons Z
    Muscle Nerve; 2020 Sep; 62(3):321-326. PubMed ID: 32415876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remaining Agile in the COVID-19 pandemic healthcare landscape - How we adopted a hybrid telemedicine Geriatric Oncology care model in an academic tertiary cancer center.
    Chen M; Mohd Said N; Mohd Rais NC; Ho F; Ling N; Chun M; Ng YS; Eng WN; Yao Y; Korc-Grodzicki B; Pang A
    J Geriatr Oncol; 2022 Jul; 13(6):856-861. PubMed ID: 35461791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of connected digital products in clinical research following the COVID-19 pandemic: a comprehensive analysis of clinical trials.
    Marra C; Gordon WJ; Stern AD
    BMJ Open; 2021 Jun; 11(6):e047341. PubMed ID: 34158302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of telecommunication and virtualization among ongoing and discontinued COVID-19 clinical trials: A cross-sectional analysis.
    Greenough MC; Sajjadi NB; Rucker B; Vassar M; Hartwell M
    Contemp Clin Trials; 2022 Mar; 114():106681. PubMed ID: 35045363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adapting to a Pandemic - Conducting Oncology Trials during the SARS-CoV-2 Pandemic.
    Tan AC; Ashley DM; Khasraw M
    Clin Cancer Res; 2020 Jul; 26(13):3100-3103. PubMed ID: 32312892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the use and challenges of implementing virtual visits during COVID-19 in primary care and lessons for sustained use.
    Mohammed HT; Hyseni L; Bui V; Gerritsen B; Fuller K; Sung J; Alarakhia M
    PLoS One; 2021; 16(6):e0253665. PubMed ID: 34166441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change?
    Lorusso D; Ray-Coquard I; Oaknin A; Banerjee S
    ESMO Open; 2020 Oct; 5(5):e000924. PubMed ID: 33051193
    [No Abstract]   [Full Text] [Related]  

  • 31. Conducting a supportive oncology clinical trial during the COVID-19 pandemic: challenges and strategies.
    Deng J; Lukens JN; Cohn JC; McMenamin E; Murphy B; Spinelli BA; Murphy N; Steinmetz AK; Landriau MA; Lin A
    Trials; 2022 Nov; 23(1):927. PubMed ID: 36348346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the COVID-19 Pandemic on Oncology Clinical Research in Latin America (LACOG 0420).
    Lara Gongora AB; Werutsky G; Jardim DL; Nogueira-Rodrigues A; Barrios CH; Mathias C; Maluf F; Riechelmann R; Fraga M; Gomes H; William WN; Yamada CAF; de Castro G; Rosa DD; de Melo AC; Sala R; Bustamante E; Bretel D; Arrieta O; Cardona AF; Bastos DA
    JCO Glob Oncol; 2021 Apr; 7():649-658. PubMed ID: 33956499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of patients with cancer during the COVID-19 pandemic: The Italian perspective on the second wave.
    Indini A; Pinotti G; Artioli F; Aschele C; Bernardi D; Butera A; Defraia E; Fasola G; Gamucci T; Giordano M; Iaria A; Leo S; Ribecco AS; Rossetti R; Savastano C; Schena M; Silva RR; Grossi F; Blasi L
    Eur J Cancer; 2021 May; 148():112-116. PubMed ID: 33743478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Communication Technology to Improve Clinical Trial Participation in Adolescents and Young Adults With Cancer: Consensus Statement From the Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network.
    Avutu V; Monga V; Mittal N; Saha A; Andolina JR; Bell DE; Fair DB; Flerlage JE; Frediani JN; Heath JL; Kahn JM; Reichek JL; Super L; Terao MA; Freyer DR; Roth ME
    JCO Oncol Pract; 2022 Mar; 18(3):224-231. PubMed ID: 34905405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telemedicine in geriatric oncology - lessons learned from the COVID-19 experience.
    Cabrera Chien L; Uranga C; Katheria V
    Curr Opin Support Palliat Care; 2024 Jun; 18(2):100-105. PubMed ID: 38652459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digitally-Enabled Remote Care for Cancer Patients: Here to Stay.
    Kaye R; Rosen-Zvi M; Ron R
    Semin Oncol Nurs; 2020 Dec; 36(6):151091. PubMed ID: 33223410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Essential Case Management Practices Amidst the Novel Coronavirus Disease 2019 (COVID-19) Crisis: Part 1: Tele-Case Management, Surge Capacity, Discharge Planning, and Transitions of Care.
    Tahan HM
    Prof Case Manag; 2020; 25(5):248-266. PubMed ID: 32452941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities.
    Fontana E; Arkenau HT
    Cancer Treat Rev; 2020 Aug; 88():102047. PubMed ID: 32544543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Efficiency and Safety Outcomes of Virtual Care for Oncology Patients During the COVID-19 Pandemic.
    Hsiehchen D; Muquith M; Haque W; Espinoza M; Yopp A; Beg MS
    JCO Oncol Pract; 2021 Sep; 17(9):e1327-e1332. PubMed ID: 34152833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium.
    Shimizu T; Kim DW; Loong HH; Lin CC; Ng MC; Yamamoto N; Ma B; Tan DS
    Asia Pac J Clin Oncol; 2021 Aug; 17(4):388-395. PubMed ID: 33502085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.